Navigation Links
Global Intravenous (IV) Iron Drugs Industry
Date:6/1/2011

quirement in Chronic Kidney Disease II-7

Classification of Iron Deficiency in CKD II-7

Treating Iron Deficiency in CKD Patients II-7

Side Effects of Iron Supplementation in CKD II-8

Methods of Restoring Iron II-8

Oral Iron Therapy II-9

IV Iron-Infusion Therapy II-9

Intravenous (IV) Iron II-9

Conditions for Receiving Iron Injections II-10

Injection Procedure II-11

Categories of Iron Injections II-11

Ferumoxytol II-11

Iron Dextran II-12

Carbohydrate Iron II-12

Suitability of IV Iron Preparation II-12

Suitability of Regimen II-13

Management of Iron Doses II-13

Effectiveness of Iron Injection II-14

Requirement of Test Dose II-14

Side Effects of Iron Injections II-15

Iron Therapy: Caution II-15

Relevance of Iron Infusion Time II-15

Iron Overdose II-15

Iron-Out-of-Balance Therapies II-16

Blood Donation II-16

Therapeutic Phlebotomy II-16

Red Cell Apheresis II-16

Iron Chelation Therapy II-16

Iron-Chelating Drugs II-17

Desferrioxamine or Desferal II-17

Deferiprone or Ferriprox II-17

Conditions for Undergoing Iron Chelation Therapy II-17

Kinds of Chelation Therapy II-18

Side Effects Caused by IV Iron Chelation II-18

Conclusion II-19

3. SELECT IV IRON DRUGS PRESCRIBED FOR IRON DEFICIENCY II-20

Iron Sucrose (Venofer®) II-20

Iron dextran (InFed®, Dexferrum®) II-20

Sodium Ferric Gluconate (Ferrlecit®) II-21

Ferumoxytol (FerahemeTM) II-21

Ferric Carboxymaltose (Ferinject®, Injectafer®) II-22

4. SOLUBLE FERRIC PYROPHOSPHATE (SFP): A PIPELINE DRUG II-23

5. CLINICAL TRIALS II-24

Rockwell Medical Technologies Presents Positive Clinical Data

on Phase IIb Study of SFP II-24

FAIR-HF Study Meets Primary En
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Reportlinker Adds Hearing Aid Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017
2. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2011 Global Healthcare Conference in New York
3. Reportlinker Adds Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
4. Reportlinker Adds Cardiovascular Monitoring and Diagnostic Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
5. Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
6. VisiInc PLC and MMRGlobal Announce Agreement to Launch MyMedicalRecords Australia
7. Neurocrine Biosciences to Present at the Jefferies 2011 Global Healthcare Conference
8. Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference
9. Unilife to Present at the 2011 Jefferies Global Healthcare Conference in New York City
10. Amicus Therapeutics to Present at Jefferies 2011 Global Healthcare Conference on Tuesday, June 7, 2011
11. Derycz Scientific Hires AstraZeneca Executive to Drive Global Sales Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 24, 2014  Conkwest, Inc., the Natural Killer ... Natural Killer (NK) cell-line platform, Neukoplast® (NK-92™) as ... Soon-Shiong , NantWorks founder, physician scientist and biotechnology ... purchase approximately $48 million of the Company,s Class ... he will be named Co-Chairman of the Conkwest ...
(Date:12/24/2014)... -- PuraMed BioScience®, Inc., (OTC Pink: PMBS), a researcher, ... products, announced it received the initial funding to begin ... relief product, for planned distribution to 1,000 medical and ... Washington State , and ... Advanced headache relief gel formulation completed, PuraMed BioScience has ...
(Date:12/24/2014)... 2014 LifeScienceIndustryResearch.com adds ... Syringe Industry of 178 pages providing 10 ... library. The 2014 Market Research ... a professional and deep research report on ... the report introduces Disposable Syringe basic information ...
Breaking Medicine Technology:Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5
... DUSA Pharmaceuticals, Inc.® (Nasdaq: DUSA ), a ... it has been named to Deloitte,s 2010 Technology Fast ... DUSA as one of the Top 500 fastest growing ... in North America.  Rankings are based on percentage of ...
... Oct. 26 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... Officer of Neurocrine Biosciences, will be presenting at the Oppenheimer ... The live presentation takes place on Tuesday, November 2, ... Time.  The presentation will be webcast and may be accessed ...
Cached Medicine Technology:DUSA Pharmaceuticals Named to Deloitte's 2010 Technology Fast 500 List of Fastest Growing Companies in North America 2
(Date:12/25/2014)... (PRWEB) December 26, 2014 ... BambooFlooringChina.com combines beauty, strength and durability. Today, the ... promotion, which is valid until Jan. 30, 2015. ... grain of traditional hardwood. BambooFlooringChina.com is a well-known ... help consumers worldwide to find a reliable bamboo ...
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) – ... the current treatment landscape, unmet needs, current pipeline ... Stivarga is a drug which is used in ... Ingelheim is developing nintedanib (BIBF-1120), an orally available ... in the US, Europe, and Japan. The drug ...
(Date:12/25/2014)... 2014 The report “TS-1 (Colorectal Cancer) ... the current treatment landscape, unmet needs, current pipeline and ... an anti-cancer drug which is typically used for treating ... used for treating gastric cancer and pancreatic cancer. TS-1 ... drug was first approved in 1999 in Japan for ...
(Date:12/25/2014)... New York, New York (PRWEB) December 25, 2014 ... of the 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ... Liebhard LLP reports. According to an Order issued in ... November 20th, the Court will convene an open conference ... Federal Building and United States Courthouse in West Palm ...
(Date:12/25/2014)... months the trends for evening dresses shift and ... of the hottest styles in the next few months.” The ... 26 A-line sweetheart evening dresses, and announces the availability of ... trying our best to help a lady to show off ... prices, we provide discounted delivery costs to our customers worldwide. ...
Breaking Medicine News(10 mins):Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3
... Flu Outbreak Highlights Influenza Virus Research at Drexel University*PHILADELPHIA, ... has demonstrated the importance of natural killer, or ... These findings may help us understand how the body,s ... swine flu.While no studies have been conducted on the ...
... 1 With the healthcare,reform debate picking up ... National,Hospice and Palliative Care Organization,s board of directors ... calls attention to critical,factors which legislators, regulators, policy ... reform proposals. , Healthcare ...
... people with back pain return to work will be announced ... , It is estimated that it costs society in excess ... off work because of back pain. Around 80% of these ... work production and associated wage replacement benefits. , "These ...
... paper published in the latest issue of the open ... evaluates consumers, experiences with the Indivo personally controlled health ... in the Children,s Hospital Informatics Program (CHIP) more than ... providers including Dossia, Microsoft and Google. This is the ...
... with higher income levels, study finds , , FRIDAY, May ... education and income tend to eat healthier diets, but ... (lower calorie/higher nutrient content), a U.S. study finds. , ... obesity, type 2 diabetes, cardiovascular disease and some forms ...
... Charles Ericsson, head of clinical infectious disease at the University ... about what scientists know right now about the swine ... , "Swine influenza is a known cause of flu ... can acquire the ability to attack humans," Ericsson explained. Formally ...
Cached Medicine News:Health News:Natural Killer Cells May Help Protect Against New Strains of Influenza Virus 2Health News:Natural Killer Cells May Help Protect Against New Strains of Influenza Virus 3Health News:Healthcare Reform Resolution Issued by National Hospice and Palliative Care Organization 2Health News:New guidance on making work less of a pain in the back 2Health News:New study evaluates community response to personally controlled health information 2Health News:New study evaluates community response to personally controlled health information 3Health News:More Educated Choose Healthier Foods, But Pay More 2Health News:Swine Flu: A Primer 2Health News:Swine Flu: A Primer 3
... Siemens introduces the AXIOM Artis ... first biplane magnetic navigation system equipped ... both planes, which is uniquely capable ... of catheter-based procedures to facilitate increased ...
... AXIOM Artis dTC is a versatile ... the cardiology department from preparation to ... interventional procedures. With AXIOM Artis dTC, your ... the cardiology department that leaves you free ...
The AXIOM Artis TC is ideal for applications above and beyond standard cardioangiography, and features:, Single plane C-Arm, ceiling-mounted, Full-size CCD camera, ...
... AXIOM Artis BC is a ... system architecture ideal for cardiological ... and ergonomic architecture enables you ... configuration to focus on:, ...
Medicine Products: